11-Beta Dehydrogenase Type 2 Activity Is Not Reduced in Treatment Resistant Hypertension.

Ghazi L, Dudenbostel T, Hachem ME, Siddiqui M, Lin CP, Oparil S, Calhoun DA. 11-Beta Dehydrogenase Type 2 Activity Is Not Reduced in Treatment Resistant Hypertension. Am J Hypertens. 2017 May 01; 30(5):518-523.

View in: PubMed

subject areas

11-beta-Hydroxysteroid Dehydrogenase Type 2
Adult
Aged
Antihypertensive Agents
Blood Pressure
Cortisone
Cross-Sectional Studies
Drug Resistance
Drug Therapy, Combination
Female
Humans
Hydrocortisone
Hypertension
Male
Middle Aged
Retrospective Studies

authors with profiles

David Calhoun

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support